Compare AbCellera Biologics Inc (ABCL) vs American Superconductor Corporation (AMSC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs American Superconductor Corporation — how do they compare? AbCellera Biologics Inc trades at $9.03 (market cap $2.99B), while American Superconductor Corporation trades at $32.63 (market cap $1.56B). The key difference: AbCellera Biologics Inc is the larger of the two by market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, American Superconductor Corporation nearer its low. Which is the better fit depends on your goals.
| ABCL | AMSC | |
|---|---|---|
Market Cap | $2.99B | $1.56B |
Sector | Health | Technology |
52-Week High | $9.76 | $66.68 |
52-Week Low | $2.78 | $25.95 |
Enterprise Value | $2.58B | $1.42B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
AMSC trades at $32.77, down 0.41% with bearish technical signals including RSI overbought conditions and negative cash flow trends. The company reported strong revenue growth of 30% year-over-year in Q1 2026 to $94.1 million but faces margin pressure, with earnings missing estimates. Record orders above $130 million and a $400 million backlog provide visibility, though valuation metrics show mixed signals with a reasonable P/E of 10.06 but elevated EV/EBITDA of 63.13.
Outlook remains cautiously optimistic given strong order pipeline and exposure to energy infrastructure growth, particularly in grid solutions and data center markets. Key risks include margin compression from cost pressures and execution challenges in integrating recent growth. Analyst consensus leans bullish with 53% buy ratings, but investors should monitor Q3 earnings delivery and cash flow improvement for sustained upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About American Superconductor Corporation
AMSC provides energy technology solutions for smarter and cleaner power grids. It offers wind turbine electronic controls and advanced grid systems that enhance the reliability and efficiency of renewable energy networks.
Read more on AMSC →
